Evercore ISI analyst issues OUTPERFORM recommendation for UAL on July 17, 2025 08:36PM ET. The previous analyst recommendation was Outperform.UAL was trading at $91.22 at issue of the analyst recommendation.The...
Bank of America Securities analyst issues NEUTRAL recommendation for JNJ on July 17, 2025 03:37PM ET. The previous analyst recommendation was Neutral.JNJ was trading at $163.09 at issue of the...
Guggenheim analyst issues NEUTRAL recommendation for JNJ on July 17, 2025 03:37PM ET. The previous analyst recommendation was Neutral.JNJ was trading at $163.09 at issue of the analyst recommendation.The overall...
Bank of America Securities analyst issues NEUTRAL recommendation for JNJ on July 17, 2025 03:37PM ET. The previous analyst recommendation was Neutral.JNJ was trading at $163.09 at issue of the...
Guggenheim analyst issues NEUTRAL recommendation for JNJ on July 17, 2025 03:37PM ET. The previous analyst recommendation was Neutral.JNJ was trading at $163.09 at issue of the analyst recommendation.The overall...
Bank of America Securities analyst issues NEUTRAL recommendation for JNJ on July 17, 2025 03:37PM ET. The previous analyst recommendation was Neutral.JNJ was trading at $163.09 at issue of the...
Bank of America Securities analyst issues NEUTRAL recommendation for JNJ on July 17, 2025 03:37PM ET. The previous analyst recommendation was Neutral.JNJ was trading at $163.09 at issue of the...
Guggenheim analyst issues NEUTRAL recommendation for JNJ on July 17, 2025 03:37PM ET. The previous analyst recommendation was Neutral.JNJ was trading at $163.09 at issue of the analyst recommendation.The overall...
Piper Sandler analyst issues OVERWEIGHT recommendation for DVN on July 17, 2025 01:17PM ET. The previous analyst recommendation was Overweight.DVN was trading at $32.54 at issue of the analyst recommendation.The...
UBS analyst issues BUY recommendation for JNJ on July 17, 2025 12:43PM ET. The previous analyst recommendation was Buy.JNJ was trading at $162.74 at issue of the analyst recommendation.The overall...
